Top Buy
| Security | Buy ▼ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 42 | 0 | 8 | 0 | €68.50 | €75.67 | 10.467% |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | €55.00 | €83.92 | 52.575% |
| Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | €71.50 | €83.92 | 17.371% |
| Trinity Biotech ADR | 27 | 0 | 3 | 0 | €0.41 | - | - |
| G1 Therapeutics | 21 | 1 | 0 | 0 | €3.74 | €10.54 | 181.909% |
| TG Therapeutics Inc. | 21 | 2 | 0 | 0 | €17.70 | €28.06 | 58.556% |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.10 | - | - |
| EyePoint Pharmaceuticals Inc. | 21 | 1 | 0 | 0 | €8.98 | €27.91 | 210.896% |
| Sutro Biopharma Inc | 21 | 0 | 0 | 0 | €4.08 | €11.04 | 170.647% |
| Akero Therapeutics Inc | 18 | 0 | 0 | 0 | €24.43 | €38.62 | 58.097% |
| Krystal Biotech | 17 | 0 | 0 | 0 | €187.65 | €186.59 | -0.565% |
| Corcept Therapeutics Inc. | 17 | 0 | 3 | 0 | €35.33 | €37.29 | 5.542% |
| Geron Corp. | 17 | 0 | 1 | 0 | €4.34 | €5.56 | 28.133% |
| Esperion Therapeutis.Inc. | 17 | 1 | 1 | 0 | €2.10 | €8.55 | 307.122% |
| Intellia Therapeutics Inc | 17 | 1 | 0 | 0 | €24.14 | €60.53 | 150.764% |
| Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | €45.00 | €46.37 | 3.044% |
| Rigel Pharmaceutical Inc. | 14 | 0 | 1 | 0 | €0.74 | €13.82 | 1767.203% |
| Sangamo Therapeutics Inc. | 13 | 17 | 1 | 5 | €0.67 | €4.10 | 508.275% |
| MacroGenics Inc. | 13 | 0 | 1 | 0 | €5.05 | €11.86 | 134.798% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €16.26 | €24.44 | 50.279% |
| Affimed N.V. | 12 | 6 | 0 | 0 | €0.55 | €6.61 | 1095.570% |
| Verastem Inc. | 12 | 0 | 2 | 0 | €2.44 | €17.56 | 619.508% |
| Twist Bioscience Corp | 11 | 0 | 1 | 0 | €50.90 | €53.41 | 4.922% |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €2.69 | €4.63 | 71.707% |
| Prothena Corp. plc | 11 | 0 | 0 | 0 | €21.20 | €79.47 | 274.839% |